CO6811859A2 - Método de tratamiento de los trastornos de la visión - Google Patents

Método de tratamiento de los trastornos de la visión

Info

Publication number
CO6811859A2
CO6811859A2 CO13275578A CO13275578A CO6811859A2 CO 6811859 A2 CO6811859 A2 CO 6811859A2 CO 13275578 A CO13275578 A CO 13275578A CO 13275578 A CO13275578 A CO 13275578A CO 6811859 A2 CO6811859 A2 CO 6811859A2
Authority
CO
Colombia
Prior art keywords
treatment
vision disorders
vision
disorders
Prior art date
Application number
CO13275578A
Other languages
English (en)
Inventor
Craig Smith
Yi-Zohng Wang
Michael Bartlett
Original Assignee
Novartis Ag
Vital Art And Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Vital Art And Science Inc filed Critical Novartis Ag
Publication of CO6811859A2 publication Critical patent/CO6811859A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
    • A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0077—Devices for viewing the surface of the body, e.g. camera, magnifying lens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/117—Identification of persons
    • A61B5/1171—Identification of persons based on the shapes or appearances of their bodies or parts thereof
    • A61B5/1172—Identification of persons based on the shapes or appearances of their bodies or parts thereof using fingerprinting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
    • A61B5/6898—Portable consumer electronic devices, e.g. music players, telephones, tablet computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
    • A61B5/749—Voice-controlled interfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Multimedia (AREA)
  • Cell Biology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CO13275578A 2011-05-27 2013-11-22 Método de tratamiento de los trastornos de la visión CO6811859A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161490774P 2011-05-27 2011-05-27

Publications (1)

Publication Number Publication Date
CO6811859A2 true CO6811859A2 (es) 2013-12-16

Family

ID=46062771

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13275578A CO6811859A2 (es) 2011-05-27 2013-11-22 Método de tratamiento de los trastornos de la visión

Country Status (16)

Country Link
US (1) US20140114208A1 (es)
EP (1) EP2714734A1 (es)
JP (1) JP2014516986A (es)
KR (1) KR20140043351A (es)
CN (1) CN103703025A (es)
AU (1) AU2012262921A1 (es)
BR (1) BR112013029713A2 (es)
CA (1) CA2834373A1 (es)
CL (1) CL2013003399A1 (es)
CO (1) CO6811859A2 (es)
IL (1) IL229192A0 (es)
MX (1) MX2013013940A (es)
RU (1) RU2013158328A (es)
SG (1) SG194471A1 (es)
TW (1) TW201249459A (es)
WO (1) WO2012166287A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9527925B2 (en) 2011-04-01 2016-12-27 Boehringer Ingelheim International Gmbh Bispecific binding molecules binding to VEGF and ANG2
US9314154B2 (en) 2011-10-17 2016-04-19 The Board Of Trustees Of The Leland Stanford Junior University System and method for providing analysis of visual function using a mobile device with display
US9462941B2 (en) 2011-10-17 2016-10-11 The Board Of Trustees Of The Leland Stanford Junior University Metamorphopsia testing and related methods
WO2014194182A1 (en) 2013-05-31 2014-12-04 The Board Of Trustees Of The Leland Stanford Junior University Modular lens adapters for mobile anterior and posterior segment ophthalmoscopy
US11372479B2 (en) 2014-11-10 2022-06-28 Irisvision, Inc. Multi-modal vision enhancement system
US11546527B2 (en) 2018-07-05 2023-01-03 Irisvision, Inc. Methods and apparatuses for compensating for retinitis pigmentosa
US10561315B2 (en) 2015-03-25 2020-02-18 The Board Of Trustees Of The Leland Stanford Junior University Modular adapters for mobile ophthalmoscopy
WO2016205709A1 (en) 2015-06-18 2016-12-22 Digisight Technologies, Inc. Adapter for retinal imaging using a hand held computer
AU2017206114A1 (en) * 2016-01-08 2018-08-02 Clearside Biomedical, Inc. Methods and devices for treating posterior ocular disorderswith aflibercept and other biologics
JP6664115B2 (ja) * 2016-03-15 2020-03-13 原　英彰 アフリベルセプトによる網膜保護作用
RU2634009C1 (ru) * 2016-12-26 2017-10-23 Николай Игоревич Овечкин Способ определения степени нарушения зрения при витреоретинальных заболеваниях
US10413172B2 (en) 2017-12-11 2019-09-17 1-800 Contacts, Inc. Digital visual acuity eye examination for remote physician assessment
WO2019160962A1 (en) 2018-02-13 2019-08-22 Frank Werblin Methods and apparatus for contrast sensitivity compensation
WO2019237033A1 (en) 2018-06-09 2019-12-12 Sensus Holistic Technologies, Llc Devices, systems and methods for self-administered therapy
US12023146B2 (en) * 2020-10-08 2024-07-02 International Business Machines Corporation Multi-modal lung capacity measurement for respiratory illness prediction
CN112442534B (zh) * 2020-11-06 2022-03-15 温州医科大学 循环血外泌体miR-146a-5p作为视网膜静脉阻塞治疗及预后评估标志物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110112860A1 (en) * 2004-07-28 2011-05-12 Informedix, Inc. Medical treatment monitoring system and method
US8668334B2 (en) 2006-02-27 2014-03-11 Vital Art And Science Incorporated Vision measurement and training system and method of operation thereof
ES2390499T3 (es) * 2006-06-12 2012-11-13 Opko Pharmaceuticals, Llc Composiciones y métodos para la inhibición de la angiogénesis por sirna
US8066376B2 (en) 2008-05-01 2011-11-29 Vital Art & Science Incorporated Dynamic shape discrimination vision test
US9033508B2 (en) 2009-05-09 2015-05-19 Vital Art And Science, Llc Handheld vision tester and calibration thereof
PT2427095T (pt) 2009-05-09 2023-10-13 Genentech Inc Sistema de avaliação e rastreio de visão de descriminação de forma
EP2482804A1 (en) * 2009-10-01 2012-08-08 Evonik Degussa Corporation Microparticle compositions and methods for treating age-related macular degeneration

Also Published As

Publication number Publication date
KR20140043351A (ko) 2014-04-09
CN103703025A (zh) 2014-04-02
SG194471A1 (en) 2013-12-30
CA2834373A1 (en) 2012-12-06
NZ616353A (en) 2015-05-29
CL2013003399A1 (es) 2014-09-05
BR112013029713A2 (pt) 2016-09-06
EP2714734A1 (en) 2014-04-09
US20140114208A1 (en) 2014-04-24
MX2013013940A (es) 2014-01-23
RU2013158328A (ru) 2015-07-10
WO2012166287A1 (en) 2012-12-06
IL229192A0 (en) 2013-12-31
TW201249459A (en) 2012-12-16
JP2014516986A (ja) 2014-07-17
AU2012262921A1 (en) 2013-11-21

Similar Documents

Publication Publication Date Title
CO6811859A2 (es) Método de tratamiento de los trastornos de la visión
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
CO6791625A2 (es) Método para cultivar caña de azúcar
CO6920296A2 (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
DK2701733T3 (da) Forbindelser til behandling af neuropsykiatriske forstyrrelser
EP2773754A4 (en) Methods of Treatment
GB201110095D0 (en) Method of treatment
CO6870035A2 (es) Nuevos derivados bicíclicos de dihidroquinolina-2-ona
EP2766044A4 (en) TREATMENT OF OCULAR DISEASES
DK2747763T3 (da) (bacterio-)chlorofyllfotosensibilisatorer til behandling af øjensygdomme og -lidelser
DK2717692T3 (da) Tetrahydrocannabinol-11-syrer til anvendelse til behandling af fibrotiske sygdomme
HK1250218A1 (zh) 對接觸鏡片進行消毒的方法
BR112014016108A2 (pt) método de tratamento de perda óssea alvelar
BR112013034054A2 (pt) ésteres para tratamento de condições inflamatórias oculares
BR112013022820A2 (pt) método de tratamento
EP2906295A4 (en) METHODS OF TREATING OCULAR DISEASES
CO6811865A2 (es) Método de tratamiento de la fiebre dengue
DK2783256T3 (da) Terapeutiske briller
BR112013023142A2 (pt) método de tratamento de cabelos
SMT201600395B (it) Derivati di pantotenato per il trattamento di disturbi neurologici
SMT201500310B (it) Metodo per la prevenzione e il trattamento della sepsi
IL235874A0 (en) Treatment of ocular inflammatory diseases by laquinimod
DK2701707T3 (da) Fremgangsmåde til behandling af dyskinesi
HK1216504A1 (zh) 疾病的治療方法
BR112014007151A2 (pt) método de formação de uma lente oftálmica

Legal Events

Date Code Title Description
FC Application refused